Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement.
about
Diabetes, Epstein-Barr virus and extranodal natural killer/T-cell lymphoma in India: Unravelling the plausible nexusDiabetes and immunity to tuberculosis.The effect of hyperglycaemia on in vitro cytokine production and macrophage infection with Mycobacterium tuberculosis.To cross-link or not to cross-link? Cross-linking associated foreign body response of collagen-based devices.Exendin-4 improves resistance to Listeria monocytogenes infection in diabetic db/db mice.Microscopy visualisation confirms multi-species biofilms are ubiquitous in diabetic foot ulcers.Impact of Obesity and Metabolic Syndrome on Immunity.Proresolution therapy for the treatment of delayed healing of diabetic wounds.Increased saturated fatty acids in obesity alter resolution of inflammation in part by stimulating prostaglandin productionRespiratory Burst Process in Diabetic Children.Diabetes as an increasingly common comorbidity among patient hospitalizations for tuberculosis in the USA.Mycobacterium avium Infection of Nasal Septum in a Diabetic Adult: A Case Report.Platelet, monocyte and neutrophil activation and glucose tolerance in South African Mixed Ancestry individuals.Oxidative stress induced by Se-deficient high-energy diet implicates neutrophil dysfunction via Nrf2 pathway suppression in swine.Toll-like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes.Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic review.Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus.Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis.Translocation of Endogenous Danger Signal HMGB1 From Nucleus to Membrane Microvesicles in Macrophages.Topical Prostaglandin E Analog Restores Defective Dendritic Cell-Mediated Th17 Host Defense Against Methicillin-Resistant Staphylococcus Aureus in the Skin of Diabetic Mice.Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls.Control of Phagocytosis by Microbial Pathogens.Effect of glycemic control and type of diabetes treatment on unsuccessful TB treatment outcomes among people with TB-Diabetes: A systematic review.Innate and Adaptive Immunity to Mucorales.Immunomodulatory potential of nanocurcumin-based formulation.Too much of a good thing: How modulating LTB4 actions restore host defense in homeostasis or disease.Impaired Inflammatory Response to LPS in Type 2 Diabetes Mellitus.Excessive localized leukotriene B4 levels dictate poor skin host defense in diabetic mice
P2860
Q26751349-B33B926B-C2AE-419C-8233-C2967533E0AAQ34424824-2A852BDA-ED82-4F50-959F-CDED9C0B9274Q35558240-D473AD9D-030E-4D7B-8352-BD18F2BF3276Q35641614-518327ED-4169-4987-A417-A7410111BF22Q36306579-9A81C6A4-A874-4BA4-B3EB-513D92E4777AQ36413097-038ACD8B-856A-413D-9A52-E28F5C2A3CE8Q36476998-AB2F943C-154C-4B43-8196-EBA0EAB5088AQ36560613-2D77B954-0332-4071-9E81-64EF9809EEE0Q37038704-85B49AD4-9E8E-45AE-9F0F-AFF1AA44BB7EQ37191703-C9091CD1-A3B2-454E-8E01-1672BE50DBE1Q37356132-C1D328C8-A03C-4255-A2BB-8CA49C7563BFQ37370179-92CF47C7-7843-4624-B4C4-2CEA1A50A7FCQ37587782-3F9B094A-311D-4F87-8F11-17F0B9A02FDCQ37706635-117DF614-32DC-4107-9BFA-D812FCE7D6ABQ38184888-174F9B8D-2006-4C98-9BE0-EA9E79E48B18Q38210065-19E80E2B-B66C-498A-A8B8-2D56A8EBC331Q38363794-DBD1BBCA-8ED8-43F3-9C0F-B1C4480F1975Q38409990-827176FD-533B-48E2-9A77-6CFF651923B3Q38791503-798C6318-90BB-4B73-A357-67E70B82C43EQ40548257-9E0DE4E1-0B1D-43BE-82FB-C6809B110C45Q43935371-8F22A3A0-03E4-4406-9811-F7D860D30627Q44612676-29A2488C-A2E8-4B85-8F3F-0997CEB6A911Q46585618-AD1AC43A-D098-4F67-8B00-8FE0D1B297FFQ48163120-04990749-3690-4B84-BEE3-4687C1AB4B63Q50046156-927AEAB9-6520-4968-A895-3FDB99581E82Q50084722-9E976496-B531-420E-9F0C-35F1D2D1341DQ54250439-0079BBE7-89C8-4C2A-AA4D-20C26BBC1FE0Q58760718-39D0B43F-93EF-437A-BE70-EB9AC161047A
P2860
Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Phagocytic activity is impaire ...... s after metabolic improvement.
@ast
Phagocytic activity is impaire ...... s after metabolic improvement.
@en
Phagocytic activity is impaire ...... s after metabolic improvement.
@nl
type
label
Phagocytic activity is impaire ...... s after metabolic improvement.
@ast
Phagocytic activity is impaire ...... s after metabolic improvement.
@en
Phagocytic activity is impaire ...... s after metabolic improvement.
@nl
prefLabel
Phagocytic activity is impaire ...... s after metabolic improvement.
@ast
Phagocytic activity is impaire ...... s after metabolic improvement.
@en
Phagocytic activity is impaire ...... s after metabolic improvement.
@nl
P2093
P2860
P1433
P1476
Phagocytic activity is impaire ...... s after metabolic improvement.
@en
P2093
Albert Lecube
Cristina Hernández
Gisela Pachón
Jordi Petriz
Rafael Simó
P2860
P304
P356
10.1371/JOURNAL.PONE.0023366
P407
P577
2011-08-18T00:00:00Z